ACE & Company is an investment firm headquartered in Geneva, Switzerland, founded in 2005, that makes global investments through private markets in private equity and venture capital. It pursues three core strategies: secondaries, buyouts, and ventures, and emphasizes portfolio construction that customizes risk and return while diversifying according to a company’s development stage. The firm focuses on healthcare services, information technology, financial services, energy services, and business products and services, supported by specialized teams that aim for long-term, sustainable results across private markets. The firm has approximately 1.8 billion dollars in assets.

French Partners is a venture capital firm established in 2016 and based in Geneva, Switzerland. It operates as the first co-investment club specifically for qualified investors interested in supporting companies led by French entrepreneurs. The firm focuses on investing in early-stage firms and growing small to medium enterprises (SMEs) with revenues reaching several tens of millions of euros, particularly those aiming to enhance their international presence. French Partners typically invests between €1 million and €5 million, often taking minority stakes, either independently or in collaboration with other investors. The firm's mission is to facilitate the growth of innovative ventures founded and managed by French entrepreneurs globally.

Veris Ventures is an early-stage venture capital firm established in 2022 and located in Geneva, Luxembourg. The firm specializes in investing in innovative startups within the blockchain technology sector, as well as in cryptocurrency and Internet of Things (IoT) industries. With a focus on supporting emerging technologies, Veris Ventures aims to foster the growth of companies that are positioned at the forefront of digital transformation.

Blufolio is a Swiss-based blockchain venture capital firm headquartered in Versoix near Geneva. It invests in technology startups operating in blockchain and sustainability sectors, employing equity and token investment strategies to support early-stage companies. The firm leverages a network of blue-chip partners—including Swisscom Blockchain, Zurich Insurance and KPMG—to bridge traditional institutional capital with the blockchain ecosystem and help portfolio companies scale.

Inovnis is a venture capital firm founded in 2019 and based in Geneva, Switzerland, that makes venture investments across diverse sectors and geographies, with a focus on blockchain, restaurants, and real estate.

Founded in 2019 and based in Geneva, Switzerland, Olive Capital is an angel network that provides its members access to investment opportunities in innovative, early-stage companies. Focusing primarily on the web3 sector, they leverage a deep global network of entrepreneurs to offer unique investment prospects.

Founded in 2020, Climb Ventures is a Geneva-based venture capital firm focusing on early to late-stage investments in tech startups across Europe. They prioritize sectors such as digital services, consumer internet, and emerging technologies.

Reuben Brothers is a family office based in Geneva, Switzerland. Founded in 2002, the firm concentrates on private equity and venture capital investments, pursuing opportunities beyond its real estate development activities and debt financing.

Bamboo Capital Partners is a private equity and venture capital firm established in 2007, with its headquarters in Geneva, Switzerland, and additional offices in Bogotá, Luxembourg City, Nairobi, and Singapore. The firm focuses on impact investing, targeting early-stage and middle-market companies across various sectors, including microfinance, fast-moving consumer goods, financial inclusion, healthcare, education, energy, agriculture, and sanitation. Bamboo Capital Partners aims to invest globally, typically seeking equity investments ranging from $0.25 million to $9 million. By combining geographical and sector expertise, the firm endeavors to foster businesses that generate both financial returns and positive social impact.

TOTAL Impact Capital is a global impact investment firm headquartered in Bethesda, Maryland, with offices in New York, San Francisco, Geneva, Monaco and Nairobi. It provides capital and advisory services to enterprises, governments and nonprofits to address social and environmental challenges, using market-based approaches that aim for measurable financial returns alongside positive social impact. The firm invests across sectors such as healthcare, environment, education, sustainable agriculture, financial services, clean water and other cleantech and sustainability themes, and it supports expansion and growth through debt, equity and hybrid instruments, typically in the range of three to thirty million dollars. The firm operates worldwide with particular emphasis on Africa and the United States and leverages its network to source scalable ventures that address basic human needs and broader development goals.

Volta Circle is a London-based single-family office established in 2019 that invests in technology-driven startups across climate, food, and circularity with the aim of enabling founders to create maximum value, scale, and impact. The team operates across Europe and Asia, including Geneva, Milan, London, and Bangkok. The firm follows an evergreen approach, primarily targeting early-stage opportunities (seed to Series A) with capability for follow-on investments, and focuses on circular economy solutions that prevent pollution, enable closed-loop consumption, and valorize waste. Its investment focus covers supply chain optimization, novel materials, recommerce platforms, responsible brands, waste management, and advanced recycling. Volta Circle is backed by the founders of Indorama Ventures.

Established in 2021 and headquartered in Geneva, Switzerland, Tayssir Capital is an investment firm specializing in venture capital. It focuses on investments within the digital assets sector.

Ambrosia Investments is a growth-focused investment group based in Geneva, Switzerland, targeting the food, beverage, and ingredients sectors in the United States and Europe. Founded in 2016, the firm pursues minority growth capital and typically invests €2 to €20 million per deal to help entrepreneurs scale their businesses, applying its entrepreneurial and investment experience across the food and beverage value chain.

Founded in 2017, DART Ventures is a Swiss venture capital firm investing in breakthrough technologies that positively impact health and climate. The company focuses on B2B, healthtech, foodtech, clean tech, and climate tech sectors across the U.S. and Europe. DART's unique approach includes a 12-month expansion program for startups, providing strategic guidance and access to experienced partners.

Desjardins Capital is the private equity and venture capital arm of Mouvement des caisses Desjardins, based in Quebec, Canada. It provides growth capital, mezzanine, and select debt financing to early-stage through mature companies across industrial, manufacturing, technology, and service sectors, with emphasis on health care, life sciences, and biotechnology. The firm also supports cooperatives, including worker-owned and housing cooperatives, and network cooperatives, financing development, acquisitions, expansions, and succession plans. It primarily invests in Quebec and surrounding regions, and can finance growth, acquisitions, management buyouts, and modernization. Investments may be equity or debt, including unsecured loans, with instruments ranging from senior debt to equity, and tenures typically five to eight years for equity and three to five years for debt. The firm often takes minority stakes with board participation. It does not invest in natural resource exploration or financial services. Desjardins Capital traces its roots to 1974 and operates within the Desjardins Group.

Omega Funds is a Boston-based venture capital and private equity firm founded in 2004 that concentrates on early-stage investments in healthcare and biotech across North America and Western Europe, backing companies in life sciences, digital health, immunology, rare diseases, precision medicine, oncology, cybersecurity, and software-as-a-service.

Founded in 2013, Maven Ventures is a Palo Alto-based venture capital firm focusing on early-stage investments in tech companies addressing emerging consumer behavior and trends. They invest in bold founders with a vision to change the world, maintaining a concentrated strategy of 6-8 core investments annually.

Brightspark Ventures is a Canadian venture capital firm founded in 1999 that backs early-stage technology companies across Canada. It invests in seed to later-stage opportunities, with a focus on information technology, software, fintech, artificial intelligence, and related tech sectors. The firm often leads deals and coordinates a network of accredited investors to support portfolio companies, providing strategic guidance and governance while enabling management teams to focus on growth.

Established in 2020, the European Innovation Council supports innovative startups and researchers with promising ideas, focusing on early-stage companies with positive environmental, social, or governance impacts. It co-invests alongside private investors.

Founded in 1953, BDC Capital is a Canadian investment firm specializing in growth and expansion financing. It focuses on information technology, technology, energy, cleantech, and healthcare sectors across Canada.

CapHorn Invest, established in 2010, is a Paris-based venture capital firm focusing on climate and health technologies. It manages 180 million euros across two funds and has invested in over 20 companies. CapHorn primarily targets seed to Series B rounds, investing between 1 to 10 million euros in transformative technologies that combat climate change. Since 2020, it operates as a Club Deal under the financial structure of Anaxago.

Gaingels is a venture investment organization focused on LGBTQ+-founded and led companies and their allies, investing across stages from pre-seed to pre-IPO and maintaining a global portfolio. Founded in 2014 and based in New York, it operates as a syndicate with more than 130 portfolio companies and around $70 million deployed. The organization supports inclusive leadership by backing ventures that promote diverse C-suite and board representation and actively assists portfolio companies in recruiting diverse executive talent. It also fosters a global community of industry leaders, investors, operators, and entrepreneurs who pursue positive social change through business and successful investments.

Founded in 2021, Amboy Street Ventures is a venture capital firm based in Los Angeles, California. It focuses on investing in fertility, sexual health, and women's health technology startups across America and Europe.

Founded in 1970, CRV is a venture capital firm based in Palo Alto, California. With nearly $1.5 billion under management, the firm focuses on seed to series B investments in technology, consumer goods, and healthcare companies across North America.

CIBC Innovation Banking is a division of CIBC that serves entrepreneurs and investors in the innovation economy. Backed by CIBC, it offers financial capital, a broad network of connections, and insightful service to help growth-oriented companies and their investors secure funding, form partnerships, and scale operations. The bank's team combines capital solutions with practical guidance and access to a wide ecosystem of industry partners to support startups and venture-backed businesses through key growth stages.

Precursor Ventures is a San Francisco-based venture capital firm that backs early-stage startups, focusing on pre-seed and seed rounds in North America. It invests in B2B and B2C software applications and hardware across sectors including consumer, digital health, education, enterprise, fintech, marketplace, SaaS, information technology, media, and more. The firm tends to support companies in the San Francisco Bay Area, New York, and Toronto, with activity in other U.S., Canada, and Mexico markets. Typical investments range from USD 0.1 million to 0.25 million per company. Founded in 2015, Precursor Ventures emphasizes investing in people and has adopted a Diversity Term Sheet Rider.

Founded in 2004 and based in Palo Alto, California, Uncork Capital is a venture capital firm focusing on seed-stage investments in SaaS, consumer goods, healthcare, and technology companies across the United States. The firm invests out of two funds: a $200M Seed fund and a $200M Opportunity fund for larger investments in mature portfolio companies.

Verve Ventures is a European venture capital firm and startup investment platform headquartered in Switzerland. It operates a digital platform that connects qualified private investors, family offices and pension funds with startup opportunities, enabling access to private markets and portfolio diversification. Founded in 2010, the firm screens thousands of startups annually and backs a small subset after rigorous due diligence. A pan-European team supports portfolio companies and investor members with networking, hiring and strategic introductions, with offices in Zurich, Lausanne, Berlin, Paris and Cambridge. Verve Ventures focuses on science and technology, climate and energy, robotics and automation, data analytics, advanced manufacturing, clean energy infrastructure and digital health, investing from seed to growth stages across Europe. The platform and network together have funded hundreds of startups, and the firm continues to expand its ecosystem of private and institutional investors and entrepreneurs.

U.S. Venture Partners is a Menlo Park-based venture capital firm established in 1981 that concentrates on early-stage and growth investments in technology and healthcare. The firm backs business-to-business software, IT security, consumer internet, mobile, e-commerce, and IT-enabled healthcare services, as well as digital health, cloud technology, and life sciences including oncology. Its focus spans enterprise software, cybersecurity, healthcare IT, SaaS, manufacturing, and related sectors on the West Coast. The team comprises former entrepreneurs, technologists, executives, and industry experts who help portfolio companies scale and reach customers.

F-Prime Capital is a venture capital firm based in Cambridge, Massachusetts, affiliated with Fidelity Investments. It backs technology and life sciences entrepreneurs across the Americas, Europe, and Asia, drawing on Fidelity’s experience in funding early-stage companies. The firm focuses on sectors such as healthcare IT, medtech, therapeutics, fintech, frontier technologies, crypto, and broader information technology and technology-enabled services. With a global network of regional teams and affiliated funds, F-Prime provides domain expertise, strategic guidance, and industry connections to help founders build durable companies. It operates with a long-term, founder-centric approach, emphasizing value creation rather than external fundraising pressures.

Cedar Mundi Ventures is a venture capital firm established in 2016 that pursues cross-border technology investments across Europe and the Middle East, with activity in sectors including B2B, B2C, healthtech, information technology, e-commerce, edtech, and fintech.

Cycle Capital is a Montreal-based venture capital and asset management firm focused on clean technology, agtech and renewable energy. Founded in 2009, it targets development and commercialization-stage companies in North America and China, and supports portfolio growth through its network of strategic partners and advisors. The firm invests across sectors including energy storage and efficiency, green chemistry, clean transportation, smart grids, IoT for resource management, water technologies, big data and smart city solutions, with a preference for minority stakes and hands-on value creation. It maintains offices in Montreal and Toronto, with activity across Canada, the United States and China, and emphasizes helping portfolio companies scale by leveraging its sector expertise, industrial partnerships and advisory resources. Cycle Capital aims to back technology-enabled solutions that address climate change and improve process efficiency throughout a product's life cycle.

New Enterprise Associates is a U.S.-based venture capital firm founded in 1977 and headquartered in Menlo Park, California. It invests in technology and healthcare companies across stages and geographies, supporting startups from seed to growth. The firm operates globally with investments in the United States, Asia, and Brazil among others, and has a long track record of portfolio IPOs and acquisitions. It has over $19 billion in cumulative committed capital.

DAA Capital Partners is a Swiss private equity and venture capital firm founded in 2018 and headquartered in Geneva. It invests in early-stage and later-stage companies, seeking long-term value through partnerships with entrepreneurs, management teams, and investors. The firm backs a broad set of sectors, including information technology, software as a service, e-commerce, business products and services, manufacturing, the internet of things, augmented reality, artificial intelligence, machine learning, big data, and real estate technology, with a geographic focus on France, Germany and Switzerland, leveraging multidisciplinary expertise and a global network to support portfolio companies.

Hammer Team, founded in 2014 and based in Cham, Switzerland, is an investment vehicle established by Ariel Luedi. The firm focuses on supporting software companies during their startup and growth phases by providing venture capital alongside essential expertise in areas such as sales operations, product management, customer success, finance, marketing, legal, tax, and branding. In addition to its primary focus on software investments, Hammer Team also explores opportunities in real estate. The organization fosters an environment for open communication among its portfolio companies, enabling them to leverage synergies and collaboratively address challenges.

123 Investment Managers is an independent investment firm based in Paris with offices in Lyon, specializing in private asset investments across venture capital, private equity, and fund of funds. It pursues direct investments in a broad range of stages from seed to mature growth and co-investment opportunities, primarily in technology, industry, renewable energy, and consumer sectors, and also in health-related and eldercare services, hotels, clinics, and other accommodation ventures. The firm focuses on Europe, with emphasis on France, Switzerland, the United States, and Canada, and targets portfolio company enterprise values roughly €5 million to €400 million, investing typically from about €0.8 million to €8 million per deal. It also offers multi-theme private asset strategies across tourism, healthcare, infrastructure, and real estate to help private and institutional clients access unlisted French companies and long-term value creation.

Palmarium is a family office based in Lucerne, Switzerland, established in 2012. The firm specializes in alternative investments, focusing on private equity, venture capital, and real estate. With a commitment to identifying and structuring unique investment opportunities, Palmarium leverages its extensive networks and deep sector knowledge to manage complex businesses and situations effectively. In addition to its investment activities, the firm also offers advisory services, reflecting its diverse capabilities and dedication to its principals and partners.

Ecofuel Fund is a Montreal-based venture capital firm specializing in cleantech investments. It backs seed and early-stage startups developing and commercializing clean technologies across sectors such as energy, water and air technologies, waste treatment, industrial process improvement, smart transport, agriculture, and biotechnology. The firm has about $40.6 million in assets under management and is supported by Investissement Québec, BDC Capital, Fondaction, Fonds de solidarité FTQ, and CRIBIQ, the Quebec consortium for industrial bioprocess research and innovation.

First Ascent Ventures is a venture capital firm founded in 2015 and headquartered in Toronto, Canada, with additional offices in Montreal and San Francisco. It focuses on early-stage technology companies, primarily in Canada and the United States, that build enterprise B2B software leveraging cloud, AI, machine learning, big data, analytics, IoT, mobile and related technologies. The firm typically targets Series A and B rounds, investing roughly CAD 5 to 10 million per company, and often takes a board seat to guide growth. It seeks entrepreneurs and management teams capable of combining capital with strategic expertise to drive rapid growth and a successful exit. The portfolio emphasis includes software-as-a-service, data analytics, and other cloud-enabled business applications, with a preference for companies that can scale across markets.

XCEL NEXT is an early-stage venture capital firm established in 2021 and based in Taipei City, Taiwan. The firm is dedicated to investing in innovative companies across a range of sectors, including artificial intelligence, 5G applications, edge computing, mobility, health technology, smart manufacturing, fintech, blockchain, and various immersive technologies such as virtual reality and the metaverse. XCEL NEXT aims to support founders in building market-leading companies that can transform industries and enhance people's lives in an increasingly digital and interconnected world.

NEXT VENTŪRES is a venture capital firm founded in 2018 and located in Austin, Texas. The firm specializes in investments within the sports, fitness, nutrition, and wellness sectors. With a team that possesses extensive expertise and strong industry connections, NEXT VENTŪRES is equipped to generate substantial value for both its investors and portfolio companies.

Tiger Global Management is an investment firm founded in 2001 by Charles (Chase) Coleman. It allocates capital across public and private markets worldwide, with a focus on technology-enabled growth opportunities. The firm pursues public equity strategies, including long/short and growth investments, and private equity across early- to late-stage companies in multiple industries, seeking high-quality growth opportunities and guiding portfolio companies through their lifecycle.

Founded in 1989, OrbiMed is a New York-based healthcare-dedicated investment firm managing approximately $5 billion in assets. It invests across the spectrum of healthcare companies, from private start-ups to large multinational corporations, focusing on biopharmaceuticals, life sciences, digital health, medical devices, and diagnostics sectors globally.

Founded in 2019, MaC Venture Capital is a venture capital firm based in Los Angeles, California. It specializes in early-stage investments across various technology sectors, including fintech, e-commerce, logistics, and more. The firm invests in companies that benefit from shifts in cultural trends and behaviors globally.

Sunstone Life Science Ventures is a European early-stage venture capital firm focused on life science and human therapeutics. Based in Copenhagen, Denmark, it was founded in 2007 and invests in biotechnology, pharmaceutical, diagnostic equipment, and therapeutics devices, seeking to back ideas at an early stage with potential to advance human medicine. The firm targets opportunities across Northern and Western Europe, supporting science-driven companies from inception through early development. It backs teams developing novel pharmaceutical ingredients and related technologies, aiming to translate research into clinical impact. The firm emphasizes early financing to help founders accelerate product development, clinical validation, and market introduction in the life sciences space.

Ysios Capital, established in 2008, is a prominent Spanish independent venture capital firm. It specializes in providing private equity financing to early and mid-stage life science companies, focusing on those developing innovative therapeutic products and platform technologies. With approximately €350 million under management across three dedicated funds, Ysios Capital supports companies across the entire healthcare and biotechnology spectrum, with a particular emphasis on pharmaceuticals, diagnostics, and medical devices. The firm is led by a team with extensive experience in building biotech companies.

Lightrock, a venture capital firm, specializes in early-stage and growth capital investments, focusing on tech-driven businesses that address global challenges. It primarily invests in India, with a typical investment size of $0.5 million to $5 million in companies generating $0.5 million to $5 million in annual revenues. Lightrock's sectors of interest include fintech, healthcare, agriculture, education, and technology-led SME enablement platforms. It does not invest in real estate, prototypes, or business plans. Lightrock is headquartered in Bangalore, India, and operates as a subsidiary of LGT Group Foundation.

Section 32 is a California-based venture capital firm founded in 2017 by Bill Maris. It concentrates on early-stage investments in life sciences, healthcare, and technology across the United States. The firm seeks to back frontier technologies that accelerate discovery, development, and dissemination of transformative solutions that improve the human condition. Its investment scope spans artificial intelligence, enterprise software, cybersecurity, fintech, quantum computing, computational biology, and biotechnology, with multi-million-dollar checks and a diversified portfolio of companies.

New Leaf Venture Partners is a New York-based venture capital firm that focuses on healthcare technology investments, including late-stage biopharmaceutical products, early-stage medical devices, and laboratory infrastructure technologies. The firm has its roots in Sprout Group, the venture capital arm of Credit Suisse First Boston, with the healthcare technology team beginning in 1993 and spinning out in 2005 to form New Leaf Venture Partners. The firm, which operates as a registered investment adviser, concentrates on translating scientific advances into medical innovations and supports portfolio companies across the life sciences, biopharmaceuticals, medical devices, and related infrastructure sectors.

Founded in 2015, Human Capital is an investment firm based in San Francisco, California. It focuses on venture capital investments across various industries, with a particular emphasis on supporting founders and teams who share its builder mindset.